115 related articles for article (PubMed ID: 9917496)
1. Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1.
Ellerhorst J; Nguyen T; Cooper DN; Estrov Y; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):225-32. PubMed ID: 9917496
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
[TBL] [Abstract][Full Text] [Related]
4. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells.
Lu Y; Lotan R
Biochim Biophys Acta; 1999 Jan; 1444(1):85-91. PubMed ID: 9931450
[TBL] [Abstract][Full Text] [Related]
6. Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines.
Maier S; Reich E; Martin R; Bachem M; Altug V; Hautmann RE; Gschwend JE
Int J Cancer; 2000 Oct; 88(2):245-51. PubMed ID: 11004676
[TBL] [Abstract][Full Text] [Related]
7. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate.
Gillenwater A; Xu XC; Estrov Y; Sacks PG; Lotan D; Lotan R
Int J Cancer; 1998 Jan; 75(2):217-24. PubMed ID: 9462711
[TBL] [Abstract][Full Text] [Related]
8. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
[TBL] [Abstract][Full Text] [Related]
9. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
[TBL] [Abstract][Full Text] [Related]
10. Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP.
Ellerhorst JA; Stephens LC; Nguyen T; Xu XC
Prostate; 2002 Jan; 50(1):64-70. PubMed ID: 11757037
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells.
Tsubaki J; Hwa V; Twigg SM; Rosenfeld RG
Endocrinology; 2002 May; 143(5):1778-88. PubMed ID: 11956160
[TBL] [Abstract][Full Text] [Related]
12. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cells.
Bidon N; Brichory F; Thomas D; Cavalier A; Caulet-Maugendre S; Bourguet P; Dazord L
Anticancer Res; 2001; 21(2A):1049-55. PubMed ID: 11396139
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.
Wang XM; Wang X; Li J; Evers BM
Ann Surg; 1998 Jun; 227(6):922-31. PubMed ID: 9637556
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
17. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
19. Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation.
Tang SJ; Huang YM; Wang FF
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):47-56. PubMed ID: 7864828
[TBL] [Abstract][Full Text] [Related]
20. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
